Distinct immune and inflammatory response patterns contribute to the identification of poor prognosis and advanced clinical characters in bladder cancer patients

Due to the molecular heterogeneity, most bladder cancer (BLCA) patients show no pathological responses to immunotherapy and chemotherapy yet suffer from their toxicity. This study identified and validated three distinct and stable molecular clusters of BLCA in cross-platform databases based on perso...

Full description

Bibliographic Details
Main Authors: Zhenglin Chang, Rongqi Li, Jinhu Zhang, Lingyue An, Gaoxiang Zhou, Min Lei, Jiwang Deng, Riwei Yang, Zhenfeng Song, Wen Zhong, Defeng Qi, Xiaolu Duan, Shujue Li, Baoqing Sun, Wenqi Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1008865/full

Similar Items